Ultrastuctural organization of carcinoma Lewis (3LL) cells during cisplatin resistance formation

Cytology and Genetics

Volumn 40, Issue 1, 2006, Pages 58-65

  Tregubova, N A ^a   Yurchenko, O V ^a   Todor, I N ^a   Sudyakov, V S ^a   Kulik, G I ^a   Chekhun, V F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL NUCLEUS; CYTOPLASM; DRUG EFFECT; DRUG RESISTANCE; ELECTRON MICROSCOPY; LEWIS CARCINOMA; MOUSE; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL NUCLEUS; CISPLATIN; CYTOPLASM; DRUG RESISTANCE, NEOPLASM; ENGLISH ABSTRACT; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON;

EID: 33845728468     PISSN: 05643783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gately D.P., Howel S.B. Cellular accumulation of the anticancer agent cisplatin: a review // Brit. J. Cancer. - 1993. - 67, No 6. - P. 1171-1176.
2. Evans D.L., Tibby M., Dive C. Differential sensitivity the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is dependent of the levels of drug accumulation and DNA adduct formation // Cancer Res. - 1994. - 54. - P. 1596-1603.
3. Perez R.P. Cellular and molecular determinants of cisplatin resistance // Eur. J. Cancer. - 1998. - 34. - P. 1535-1544.
4. Mejer C., Luyn M.J.A. van, Mienhuis E.F. et al. Ultrastructural morphology and localization of cisplatin-induced platinum-DNA-adducts in a cisplatin-sensitive and resistant human small cell lung cancer line using electron microscopy // Biochem. Pharm. - 2001. - 61. - P. 573-578.
5. Bergamo A., Lagliardi R., Scarcia V. et al. In vitro cycle arrest, in vivo action on solid metastasing tumors, and host toxicity of the antimetastatic drug NaMi-A and cisplatin // Pharmacol. Exp. Ther. - 1999. - 289, No 1. - P. 559-564.
6. Holdaway K.M., Finlay G.J., Baduley B.C. Relationship of cell parameters to in vitro and in vivo chemosensitivity for a series of Lewis lung carcinoma lines // Eur. J. Cancer. - 1992. - 28A, No 8/9. - P. 1427-1431.
7. Yurchenko O.V., Todor I.N., Tryndijak V.P., Tregubova N.A., Kovtonyuk O.V., Solyanik G.I., Kulik G.I., Chekchun V.F. Resistance of Guerin carcinoma cells to cisplatine; biochemical and morphological aspects // Exp. Oncol. - 2003. - 25, No 1. - P. 64-68.
8. Finlay G.J., Wilson W.R., Baguley B.C. Cytokinetic factor in drug resistance of Lewis carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures // Brit. J. Cancer. - 1987. - 56, No 6. - P. 755-762.
9. Gonzales V.M., Fuertes M.A., Alonso C., Perez J.M. Is cisplatin-induced cell death always produced by apoptosis? // Mol. Pharmacol. - 2001. - 59, No 4. - P. 657-663.
10. Knapp D.C., Mata J.E., Ready M.T. et al. Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model // Anticancer Drugs. - 2003. - 14, No 1. - P. 39-47.
11. Andrews P.A., Albrigcht K.D. Mitochondrial defects in cis-diaminedicloroplatinum(11) resistant human ovarian carcinoma cells // Cancer Res. - 1992. - 52. - P. 1895-1901.
12. Bubley G.J., Kupiec N., Sanders D. et al. Effect of DNA conformation on cisplatin adduct formation // Biochem. Pharmacol. - 1996. - 51. - P. 717-721.
13. Garcia-Sang M., Simon-Marin R., Hilario E. Morphological characterization of Lewis lung carcinoma (3LL). A light and electron microscopic study // Tumori. - 1989. - 75, No 1. - P. 23-27.
14. Paku S., Timar J., Lapis K. Ultrastructure of invasion in different tissue types by Lewis lung tumor variants // Virchows Arch. Pathol. Anat. Histopathology. - 1990. - 417, No 5. - P. 435-442.
15. Sato T., Takusagawa K., Asoo N. et al. Ultrastructure of the Lewis lung carcinoma // Eur. J. Cancer Clin. Oncol. - 1982. - 18, No 4. - P. 369-376.
16. Decaudin D., Geley S., Hirsh T. et al. Bcl-2 and Bcl-X1 antagonize the mitochondrial disfunction preceeding nuclear apoptosis induced by chemotherapeutic agents // Cancer Res. - 1977. - 57. - P. 62-67.